TITLE

Letters

PUB. DATE
February 2000
SOURCE
CMAJ: Canadian Medical Association Journal;2/08/2000, Vol. 162 Issue 3, p313
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Offers letters from readers regarding various medical issues and questions. Research by physicians in British Columbia which disproves a newspaper claim that children in some parts of the province were being prescribed methylphenidate at the highest known rate in North America; Concern regarding how students are selected for medical school and the effect the selection process has on the physician supply problem in Canada.
ACCESSION #
2783426

 

Related Articles

  • Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Peterson, Kim; McDonagh, Marian S.; Rongwei Fu // Psychopharmacology;Mar2008, Vol. 197 Issue 1, p1 

    Recommended medication prescribing hierarchies for adult attention-deficit hyperactivity disorder (ADHD) vary between different guideline committees. Few trials directly compare competing ADHD medications in adults and provide little insight for clinicians making treatment choices. The objective...

  • Methylphenidate.  // Reactions Weekly;1/15/2011, Issue 1334, p33 

    The article describes the case of a 14-year-old boy who presented with priapism while receiving treatment with immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD), referencing a study published in the August 2010 issue of the "Turkish Journal of Pediatrics."

  • Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Verster, Joris C.; Bekker, Evelijne M.; Kooij, J. J.; Buitelaar, Jan K.; Verbaten, Marinus N.; Volkerts, Edmund R.; Olivier, Berend // Psychopharmacology;Oct2010, Vol. 212 Issue 2, p277 

    Background: Declarative memory deficits are common in untreated adults with attention-deficit hyperactivity disorder (ADHD), but limited evidence exists to support improvement after treatment with methylphenidate. The objective of this study was to examine the effects of methylphenidate on...

  • A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. R�sler, Michael; Fischer, Roland; Ammer, Richard; Ose, Claudia; Retz, Wolfgang // European Archives of Psychiatry & Clinical Neuroscience;Mar2009, Vol. 259 Issue 2, p120 

    Attention-deficit/hyperactivity disorder (ADHD) affects many adults who had ADHD in childhood. Although stimulants and methylphenidate in particular are a common off-label treatment for adult patients with ADHD in European countries, little is known about their long-term efficacy and safety. A...

  • Comparison of the clinical efficacy of twice-daily Ritalin® and once-daily Equasymâ„¢ XL with placebo in children with Attention Deficit/Hyperactivity Disorder. Findling, Robert L.; Quinn, Declan; Hatch, Simon J.; Cameron, Sara J.; DeCory, Heleen H.; McDowell, Michael // European Child & Adolescent Psychiatry;Dec2006, Vol. 15 Issue 8, p450 

    To compare the efficacy and safety of two methylphenidate (MPH) formulations—once-daily modified-release MPH (EqXL, Equasym™ XL) and twice-daily immediate-release methylphenidate (MPH-IR, Ritalin®)—and placebo in children with Attention Deficit/Hyperactivity Disorder...

  • Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial. Huss, Michael; Ginsberg, Ylva; Arngrim, Torben; Philipsen, Alexandra; Carter, Katherine; Chen, Chien-Wei; Gandhi, Preetam; Kumar, Vinod // Clinical Drug Investigation;Sep2014, Vol. 34 Issue 9, p639 

    Background and Objectives: In the management of attention-deficit hyperactivity disorder (ADHD) in adults it is important to recognize that individual patients respond to a wide range of methylphenidate doses. Studies with methylphenidate modified release long acting (MPH-LA) in children have...

  • A Dose-Ranging Study of Behavioral and Pharmacological Treatment in Social Settings for Children with ADHD. Pelham, William; Burrows-MacLean, Lisa; Gnagy, Elizabeth; Fabiano, Gregory; Coles, Erika; Wymbs, Brian; Chacko, Anil; Walker, Kathryn; Wymbs, Frances; Garefino, Allison; Hoffman, Martin; Waxmonsky, James; Waschbusch, Daniel // Journal of Abnormal Child Psychology;Aug2014, Vol. 42 Issue 6, p1019 

    Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants...

  • Thinking Differently. Rogers, Adam // Newsweek;12/7/1998, Vol. 132 Issue 23, p60 

    Reports that brain scans with magnetic resonance imaging are giving hope in diagnosing attention deficit hyperactivity disorder, or ADHD. The number of children in the United States with ADHD; The use of Ritalin as a treatment; Brief details of a study by a team of Stanford University...

  • Why ritalin works. WRIGHTSON, CASSANDRA // Health (Time Inc. Health);Jan/Feb98, Vol. 12 Issue 1, p45 

    Explains the reason why Ritalin, a speedlike drug, helps hyperactive kids focus.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics